Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging
Jamshid Maddahi(University of California, Los Angeles), Joel Lazewatsky(Lantheus Medical Imaging (United States)), Magnus Dahlbom(University of California, Los Angeles), Paul D. Crane(Lantheus Medical Imaging (United States)), Michael E. Phelps(National Academy of Engineering), Johannes Czernin(University of California, Los Angeles), Richard Sparks, Heinrich R. Schelbert(Ronald Reagan UCLA Medical Center), Frank M. Bengel(Medizinische Hochschule Hannover)
Cited by 49
Related Papers
Quantitation in Positron Emission Computed Tomography
|Journal of Computer Assisted Tomography|1979|1.2k
Positron Emission Tomography in Evaluation of Dementia
|JAMA|2001|952
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease
|Proceedings of the National Academy of Sciences|2000|798
PET of Brain Amyloid and Tau in Mild Cognitive Impairment
|New England Journal of Medicine|2006|737